Loading organizations...
RelayHealth develops web-based solutions providing a secure and interoperable platform for healthcare information technology infrastructure. The company offers connectivity services and integration among diverse healthcare organizations, systems, and solutions, acting as a neutral partner within an open network environment. Its core capabilities facilitate clinical integration, care collaboration, patient access, and robust health data analytics, ensuring relevant patient data is accessible across pharmacies, clinical labs, hospitals, and medical providers.
Incorporated in 1999 by founders Gary Gannot and Giovanni Colella, RelayHealth emerged from the insight that a connected data ecosystem was crucial for supporting evolving healthcare delivery models. Their vision focused on enabling a patient-centered medical home (PCMH) environment, recognizing the need for underlying workflow and process transformation in healthcare practices to achieve this integration.
RelayHealth’s offerings serve a broad spectrum of healthcare constituents, including patients, primary care providers, pharmacies, and hospitals. The company’s long-term vision centers on empowering clients to establish the foundational infrastructure for successful certified PCMH models and adaptable future care frameworks, ultimately aiming for more streamlined and collaborative healthcare experiences.
RelayHealth has raised $48.0M across 4 funding rounds.
RelayHealth has raised $48.0M in total across 4 funding rounds.
RelayHealth is a healthcare technology company that provides secure, interoperable web-based platforms for connectivity and data exchange among patients, providers, payers, pharmacies, and other stakeholders.[1][2][5] It offers solutions like patient portals, secure messaging, electronic prescribing, claims management, financial services, and pharmacy reimbursement tools such as RelayRx Medical Billing, streamlining clinical, financial, and administrative processes to support models like Patient-Centered Medical Homes (PCMH).[1][2][3] Originally part of McKesson, RelayHealth was integrated into Change Healthcare and later acquired by UnitedHealth Group's Optum, serving over 50,000 retail pharmacies and processing billions of transactions annually with reported revenues around $1 billion.[2][3][5][4]
The company addresses fragmentation in healthcare IT by enabling real-time data sharing from sources like pharmacies, labs, and hospitals, improving care coordination, patient access, and financial performance.[1][5][7] Its growth reflects momentum through expansions like clinical service billing platforms and partnerships for medication cost transparency, positioning it as a key player in integrated care networks.[3][4]
RelayHealth emerged from McKesson's connectivity assets combined with Per-Se Technologies following McKesson's acquisition of Per-Se, formally launching as a dedicated business around 2006-2007 to unify physician-patient tools, pharmacy networks, and revenue cycle management.[6] Based in Atlanta, Georgia, it built on McKesson's existing physician-patient communication and pharmacy services, evolving into a neutral open-network platform for healthcare integration.[5][6][7] Key expansions included pharmacy solutions under McKesson Prescription Technology Solutions by 2018, with innovations like RelayRx Medical Billing co-developed with partners such as STRAND Clinical Technologies, founded in 2008 by a community pharmacist and tech expert.[3]
Pivotal moments included processing over 12.8 billion transactions, rapid website deployments using SaaS tools, and partnerships like those with CoverMyMeds for RxBenefit Clarity in 2019 and MultiCare Connected Care for electronic data exchange platforms.[4][5] Subsequent acquisitions—first into Change Healthcare, then Optum—marked its evolution into a larger ecosystem player.[2]
RelayHealth rides the wave of healthcare interoperability and digital transformation, fueled by trends like value-based care, PCMH adoption, and accountable care organizations (ACOs) that demand seamless data exchange to reduce costs and improve outcomes.[1][4] Its timing aligns with regulatory pushes for electronic health records and real-time data sharing, amplified by post-2010s shifts from fee-for-service to integrated networks amid rising chronic disease management needs.[1][3] Market forces favoring it include pharmacy expansion into clinical services, payer-provider alignment, and the explosion of digital health post-COVID, where its pharmacy and claims tools address administrative burdens.[2][3][7]
It influences the ecosystem by enabling multi-stakeholder platforms—like those with MultiCare—driving care coordination and financial insights, while acquisitions by Optum extend its reach into UnitedHealth's vast payer-provider network, accelerating adoption of standards like FHIR indirectly through practical tools.[4][6]
RelayHealth's integration into Optum positions it for deeper AI-driven analytics, predictive care coordination, and expanded telehealth connectivity as healthcare consolidates around mega-platforms.[2] Trends like personalized medicine, pharmacy-as-care-hubs, and regulatory interoperability mandates (e.g., CMS rules) will propel its growth, potentially enhancing tools for chronic disease management and real-time payer insights.[1][3] Its influence may evolve from connectivity enabler to core Optum infrastructure, powering population health at scale and shaping competitive dynamics against rivals in health IT.
Tying back to its roots as a neutral network pioneer, RelayHealth exemplifies how targeted tech bridges legacy healthcare silos, delivering enduring value in an increasingly connected ecosystem.[5]
RelayHealth has raised $48.0M in total across 4 funding rounds.
RelayHealth's investors include Venrock.
RelayHealth has raised $48.0M across 4 funding rounds. Most recently, it raised $10.0M Series F in May 2004.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2004 | $10M Series F | — | Venrock | Announced |
| Jun 1, 2003 | $6M Series E | — | Venrock | Announced |
| Jul 1, 2001 | $13M Series D | — | Venrock | Announced |
| Jan 1, 2000 | $19M Series C | — | Venrock | Announced |
